COVID-19 Vaccine Resources
Topic Collection
January 21, 2021
Topic Collection: COVID-19 Vaccine Resources
This Topic Collection focuses on vaccine-specific plans, tools, templates, and other immediately implementable resources to help with COVID-19 preparedness, response, recovery, and mitigation efforts.
The distribution and administration of vaccines to prevent COVID-19 should build on established plans. Federal, state, territorial, local, and tribal governments and their healthcare and other emergency preparedness partners have conducted extensive planning on the most effective methods to distribute and administer medical countermeasures – including vaccines – in their communities. Refer to the ASPR TRACIE Mass Distribution and Dispensing of Medical Countermeasures Topic Collection for related resources. Resources marked with an asterisk (*) appear in more than one category.
Please refer to the NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines and CDC’s Coronavirus Disease 2019 webpage for the most up-to-date guidance on COVID-19 outbreak management.
If you have COVID-19 best or promising practices, plans, tools, or templates to share with your peers, please visit the ASPR TRACIE Information Exchange COVID-19 Information Sharing Page (registration required) and place your resources under the relevant topic area. Resources specific to Vaccines can be placed under the COVID-19 Vaccines Resources Topic.
Education and Training
This page includes links to webinars and other educational information related to COVID-19 vaccination.
Login to rate, favorite, and comments on the article
This online training module provides information to healthcare workers on COVID-19 vaccine approval and safety, storage, handling, administration, and reporting.
Login to rate, favorite, and comments on the article
*
COVID-19 Real-Time Learning Network. (2020).
Vaccines and Immunity.
(Added 12/23/2020.)Centers for Disease Control and Prevention and Infectious Diseases Society of America.
This page provides a broad range of information on vaccine development and distribution planning.
Login to rate, favorite, and comments on the article
This page includes links to webinars and on-demand training for health professionals involved in the COVID-19 vaccination effort.
Login to rate, favorite, and comments on the article
This page includes links to training required or recommended in the state of Oregon, manufacturer-specific training, and other sources of optional training.
Login to rate, favorite, and comments on the article
This page offers links to vaccination training programs for health professionals.
Login to rate, favorite, and comments on the article
General Resources
This document identifies access, transparency, equity, efficacy, and safety as the guiding principles for the vaccination of nurses and other healthcare professionals.
Login to rate, favorite, and comments on the article
This Topic Collection provides links to federal, state, local, and tribal programs and resources, lessons learned, plans, tools, and templates, courses, and guidance that can help planners address the need to effectively distribute and administer medical countermeasures (MCMs) to a large number of persons in a short period of time, particularly through mass dispensing efforts led by public health authorities.
Login to rate, favorite, and comments on the article
This ASPR TRACIE TA response includes links to resources related to the approval, allocation, distribution, and administration of vaccines to prevent COVID-19.
Login to rate, favorite, and comments on the article
ASPR TRACIE. (2020).
Influenza Epidemic/ Pandemic.
U.S. Department of Health and Human Services, Office of the Assistant Secretary of Preparedness and Response.
The resources in this Topic Collection include the lessons learned from the 2009 pandemic, strategies for maintaining “business as usual” for healthcare facilities, checklists, and others that can help emergency medical staff plan for and respond to a pandemic.
Login to rate, favorite, and comments on the article
This document answers frequently asked questions about COVID-19 vaccine approval, manufacturing, allocation, and distribution for state and local disability leaders.
Login to rate, favorite, and comments on the article
Centers for Disease Control and Prevention. (2020).
COVID-19 Vaccination.
(Added 12/23/2020.) U.S. Department of Health and Human Services.
This page provides information for healthcare workers on getting vaccinated, preparing patients for vaccination, and finding additional COVID-19 vaccine resources.
Login to rate, favorite, and comments on the article
*
COVID-19 Real-Time Learning Network. (2020).
Vaccines and Immunity.
(Added 12/23/2020.)Centers for Disease Control and Prevention and Infectious Diseases Society of America.
This page provides a broad range of information on vaccine development and distribution planning.
Login to rate, favorite, and comments on the article
This document answers frequently asked questions related to COVID-19 vaccination planning.
Login to rate, favorite, and comments on the article
This page provides an overview of the four different COVID-19 vaccine types in development: whole virus, protein subunit, nucleic, and viral vector.
Login to rate, favorite, and comments on the article
This statement by 17 organizations offers seven guiding principles related to COVID-19 vaccine. It calls for transparent and scientifically rigorous vaccine development, approval, and post-marketing surveillance processes; equitable allocation of vaccine; consistent and clear public engagement and communication; a well-coordinated national distribution strategy; accounting for the readiness of the local vaccination infrastructure and workforce; prioritization and promotion of COVID-19 vaccination; and ensuring affordability and access.
Login to rate, favorite, and comments on the article
U.S. Food and Drug Administration. (2020).
COVID-19 Vaccines.
(Added 12/23/2020.) U.S. Department of Health and Human Services.
This landing page provides links to the latest information on the development and approval of COVID-19 vaccines.
Login to rate, favorite, and comments on the article
U.S. Food and Drug Administration. (2020).
Vaccine Development – 101.
(Added 12/23/2020.) U.S. Department of Health and Human Services.
This webpage describes the steps that vaccine developers follow when seeking FDA approval of a vaccine.
Login to rate, favorite, and comments on the article
Plans, Tools, and Templates
This frequently updated toolkit includes tabulated information about changes to the Emergency Use Authorization (EUA) for COVID-19 Convalescent Plasma (CCP); detailed information about blood donor referrals after COVID-19 vaccination or CCP infusion; flowcharts on investigational and EUA use, collection, and testing and labeling of CCP, and a sample flowchart for updating a deferral policy for vaccines to help evaluate donor risk following vaccination.
Login to rate, favorite, and comments on the article
This tool guides the involvement of pharmacists and pharmacy staff in institutional and community COVID-19 vaccine planning efforts. It addresses integration with institutional planning, vaccine supply and distribution, infrastructure, personnel, patient care, vaccine safety monitoring and surveillance, and legislative and regulatory controls.
Login to rate, favorite, and comments on the article
This resource guide includes information on general security and storage, procurement, pharmacy security and storage, transport, and patient care area security and storage of COVID-19 vaccine as well as management of COVID-19 vaccine returns to pharmacy and community pharmacy considerations.
Login to rate, favorite, and comments on the article
This tool allows planners to enter the state population of prioritized groups, available COVID-19 vaccine doses, and allocation approach (proportional to population or according to two different vulnerability indexes) to view the distribution of vaccine across counties and population groups.
Login to rate, favorite, and comments on the article
Immunization program managers can use this checklist to help prepare for COVID-19 vaccination efforts.
Login to rate, favorite, and comments on the article
This checklist offers steps for health departments to take in preparation for the availability of a COVID-19 vaccine.
Login to rate, favorite, and comments on the article
This page includes materials that providers can use to communicate with patients about vaccination to prevent COVID-19. Materials include fact sheets, posters, stickers, slides, social media messages, videos, and communications guides.
Login to rate, favorite, and comments on the article
This playbook can help public health departments and their response partners plan and operationalize their COVID-19 vaccination programs.
Login to rate, favorite, and comments on the article
This page includes links to the executive summaries of the COVID-19 vaccination plans of state, territorial, and local public health agencies and their partners.
Login to rate, favorite, and comments on the article
This toolkit includes various resources to support COVID-19 vaccination of long-term care facility residents and staff.
Login to rate, favorite, and comments on the article
This toolkit shares best practices for vaccine storage and handling. It includes an addendum focused on COVID-19 vaccines.
Login to rate, favorite, and comments on the article
This plan details how the Indian Health Service will prepare for and distribute COVID-19 vaccine to its Direct Service facilities, Tribal health programs, and Urban Indian Organizations.
Login to rate, favorite, and comments on the article
This press release announces the Department of Defense’s plan to distribute and administer COVID-19 vaccine to uniformed service members, dependents, retirees, civilian employees, and select contract personnel. It includes links to the department’s COVID-19 vaccine guidance and vaccine distribution and population schema.
Login to rate, favorite, and comments on the article
This plan describes department activities related to vaccination of veterans and staff, including prioritization of healthcare workers and veterans residing in long-term care facilities.
Login to rate, favorite, and comments on the article
Post-Vaccination Issues
This report details initial reports of adverse events following administration of the first dose of the Pfizer-BioNTech vaccine. Between December 14 and 23, 2020, 21 cases of anaphylaxis were reported following administration of 1,893,360 doses of vaccine.
Login to rate, favorite, and comments on the article
This page offers considerations for healthcare personnel with systemic signs and symptoms after receiving a vaccination for COVID-19.
Login to rate, favorite, and comments on the article
This page offers considerations for residents of long-term care facilities with systemic signs and systems after receiving a COVID-19 vaccine.
Login to rate, favorite, and comments on the article
This page includes information about the smartphone-based tool for personalized check-ins following vaccination to prevent COVID-19. The page offers a description of the tool and registration information.
Login to rate, favorite, and comments on the article
Risk Communication Tools and Considerations
American Health Care association and National Center for Assisted Living. (2020).
Communications Toolkit.
(Added 12/28/2020.)
This toolkit contains various resources to support the #GetVaccinated campaign, including talking points, templates, and media materials.
Login to rate, favorite, and comments on the article
This updated fact sheet provides information for pharmacists’ conversations with their customers about immunization, including tips for addressing vaccine hesitancy generally and in racial or ethnic minority populations more specifically.
Login to rate, favorite, and comments on the article
This resource highlights attitudes and behaviors associated with vaccines. It offers strategies on building vaccination acceptance and confidence that will be important to the COVID-19 vaccination effort.
Login to rate, favorite, and comments on the article
This page offers suggestions for healthcare providers on answering patient questions about vaccination to prevent COVID-19.
Login to rate, favorite, and comments on the article
This page includes materials that providers can use to communicate with patients about vaccination to prevent COVID-19. Materials include fact sheets, posters, stickers, slides, social media messages, videos, and communications guides.
Login to rate, favorite, and comments on the article
This page offers communication strategies to aid healthcare providers in talking with their patients about vaccination to prevent COVID-19.
Login to rate, favorite, and comments on the article
Centers for Disease Control and Prevention. (2020).
Vaccines.
(Added 12/28/2020.)U.S. Department of Health and Human Services.
This landing page provides information for the public about COVID-19 vaccines, recommendations, administration plans, and safety. It also includes answers to frequently asked questions.
Login to rate, favorite, and comments on the article
This article describes the side effects that many people should expect to experience following COVID-19 vaccination and discusses the importance of communicating this possibility with the public now to counter disinformation about the vaccine and misattribution of symptoms that overlap with COVID-19 infection.
Login to rate, favorite, and comments on the article
This page provides tips and sample language for communicating with the public about COVID-19 vaccination.
Login to rate, favorite, and comments on the article
The authors – members of the Working Group on Readying Populations for COVID-19 Vaccines – offer five recommendations to advance public understanding of, access to, and acceptance of COVID-19 vaccines.
Login to rate, favorite, and comments on the article
This webinar offers suggestions on how to build vaccine confidence and access in communities of color.
Login to rate, favorite, and comments on the article
Vaccine Logistics - Administration
This page is a reference for the Current Procedural Terminology code set for COVID-19 vaccine-specific codes.
Login to rate, favorite, and comments on the article
To help pharmacists, pharmacy technicians, and pharmacy interns know about the expectations and requirements for their authority to immunize during the COVID-19 pandemic, this updated table lists requirements for COVID-19 vaccinations and childhood vaccinations.
Login to rate, favorite, and comments on the article
This resource guide includes information on general security and storage, procurement, pharmacy security and storage, transport, and patient care area security and storage of COVID-19 vaccine as well as management of COVID-19 vaccine returns to pharmacy and community pharmacy considerations.
Login to rate, favorite, and comments on the article
This section of the Hospital Operations Toolkit for COVID-19 discusses strategies for hospitals to administer allocated vaccine to their staff.
Login to rate, favorite, and comments on the article
This resource provides information on sources of products and services to support COVID-19 and other vaccination campaigns.
Login to rate, favorite, and comments on the article
This one-page table compares the target populations, efficacy, administration, possible side effects, safety for pregnant/lactating individuals, storage requirements, and minimum purchase orders for the Pfizer/BioNTech and Moderna COVID-19 vaccines.
Login to rate, favorite, and comments on the article
This page provides guidance to inform vaccination clinic planning. It applies to both routine vaccination clinics as well as those established for emergencies, such as COVID-19. In addition to outlining activities necessary to operate a vaccination clinic, checklists are available for supplies and best practices.
Login to rate, favorite, and comments on the article
This page offers clinical considerations for the Pfizer-BioNTech and Moderna COVID-19 vaccines related to: administration; interchangeability with other COVID-19 vaccine products; coadministration with other vaccines; booster doses, vaccination of those with SARS-CoV-2 infection or exposure; vaccination of persons with underlying medical conditions, immunocompromised persons, pregnant or lactating people, and adolescents; patient counseling; contraindications and precautions; reporting of vaccine adverse events; and interpretation of SARS-CoV-2 test results in vaccinated persons. It includes a table to inform the triage of persons presenting for vaccination.
Login to rate, favorite, and comments on the article
This page offers information to help vaccination sites prepare for the initial assessment and management of anaphylaxis following COVID-19 vaccination. It identifies signs and symptoms for early recognition, lists medications and supplies recommended to be available at the site, instructs what steps to follow if anaphylaxis is suspected, and provides information on the post-vaccination observation period, patient counseling, and reporting of adverse events.
Login to rate, favorite, and comments on the article
This toolkit includes various resources to support COVID-19 vaccination of long-term care facility residents and staff.
Login to rate, favorite, and comments on the article
This page addresses possible concerns about the recommended use and supply of needles during this period of high demand due to COVID-19, influenza, and other vaccinations.
Login to rate, favorite, and comments on the article
This toolkit shares best practices for vaccine storage and handling. It includes an addendum focused on COVID-19 vaccines.
Login to rate, favorite, and comments on the article
This page links to toolkits on COVID-19 vaccine enrollment, coverage, reimbursement, and other information for healthcare providers, state Medicaid programs and Children’s Health Insurance Programs, health insurers, and those helping consumers and beneficiaries.
Login to rate, favorite, and comments on the article
This document provides handling information for owners and operators related to dry ice.
Login to rate, favorite, and comments on the article
This alert summarizes the needles, syringes, alcohol prep pads, and personal protective equipment that will be included in ancillary kits accompanying COVID-19 vaccine shipments.
Login to rate, favorite, and comments on the article
This paper discusses the processes and systems involved in the allocation, ordering, distribution, inventory management, tracking, administration, documentation, and reporting involved in the COVID-19 mass vaccination campaign.
Login to rate, favorite, and comments on the article
This practice advisory reviews the available evidence related to COVID-19 vaccination in pregnant and lactating patients and offers recommendations to guide conversations between providers and their patients about whether to be vaccinated.
Login to rate, favorite, and comments on the article
This guidance allows state-licensed pharmacists to order and state-licensed pharmacists and registered pharmacy interns to administer COVID-19 vaccines under the Public Readiness and Emergency Preparedness Act when certain requirements are met.
Login to rate, favorite, and comments on the article
Vaccination Logistics – Prioritization
This document analyzes how states prioritized their initial allocations of vaccine to prevent COVID-19, including whether they followed the recommendations of the Advisory Committee on Immunization Practices. Links to each state’s prioritization criteria are included.
Login to rate, favorite, and comments on the article
This issue brief identifies key issues related to COVID-19 vaccine distribution. Issues discussed include: funding for vaccine distribution; supply, logistics, and monitoring; federal, state, and local authority over vaccine requirements; insurance coverage and out-of-pocket costs; addressing racial and ethnic disparities; and communication and trust.
Login to rate, favorite, and comments on the article
This issue brief describes a review of the 64 state, territorial, and local jurisdictional immunization program COVID-19 vaccine response plans submitted to the Centers for Disease Control and Prevention. The authors summarize how jurisdictions are identifying priority populations for vaccination, identifying a network of providers to administer vaccines, developing data collection and reporting systems to track vaccine distribution, and planning a communication strategy. Also included are links to all publicly available plans.
Login to rate, favorite, and comments on the article
This page uses a map and tables to show the populations prioritized in each state by phase of vaccination.
Login to rate, favorite, and comments on the article
This toolkit provides information to counties to inform planning for equitable local distribution of COVID-19 vaccine.
Login to rate, favorite, and comments on the article
This report analyzes the initial drafts of jurisdictional COVID-19 vaccination plans submitted to CDC to identify key issues and promote promising practices.
Login to rate, favorite, and comments on the article
Vaccine Allocation and Equity
This tool allows planners to enter the state population of prioritized groups, available COVID-19 vaccine doses, and allocation approach (proportional to population or according to two different vulnerability indexes) to view the distribution of vaccine across counties and population groups.
Login to rate, favorite, and comments on the article
This page describes the partnership of CEPI, Gavi, and the World Health Organization geared towards making two billion doses of COVID-19 vaccine fairly and equitably accessible to participating countries.
Login to rate, favorite, and comments on the article
This report outlines the Advisory Committee on Immunization Practices’ COVID-19 vaccine allocation recommendations for Phase 1b (persons age 75 and older and non-healthcare frontline essential workers) and Phase 1c (persons age 65-74, essential workers not included in Phase 1b, and persons 16-64 with high-risk medical conditions).
Login to rate, favorite, and comments on the article
This report provides the rationale of the Advisory Committee on Immunization Practices behind recommending that initial, limited supply of COVID-19 vaccine be allocated to healthcare workers and residents of long-term care facilities during Phase 1a.
Login to rate, favorite, and comments on the article
The authors of this article describe a three-phased Fair Priority Model for distribution of COVID-19 vaccine that prioritizes preventing urgent harms earlier. Phase 1 addresses premature deaths and other irreversible health effects, phase 2 addresses other enduring health harms and economic and social deprivations, and phase 3 addresses community transmission.
Login to rate, favorite, and comments on the article
The report identifies four ethical principles that guide the Advisory Committee on Immunization Practices’ recommendations for initial allocation of limited COVID-19 vaccine: maximizing benefits and minimizing harms, promoting justice, mitigating health inequities, and promoting transparency.
Login to rate, favorite, and comments on the article
This article summarizes the quantities of various COVID-19 vaccine candidates that have been pre-ordered and their planned distribution in various countries.
Login to rate, favorite, and comments on the article
This consensus study report offers a phased framework based on ethical and procedural principles for equitable allocation of COVID-19 vaccine that reduces severe morbidity and mortality and negative societal effects of the pandemic. In addition to the framework, the authors addressed implementation challenges related to program administration, risk communication and community engagement, vaccine acceptance, and global equity in allocation.
Login to rate, favorite, and comments on the article
This report offers an ethical allocation framework and suggestions for vaccine distribution. The framework is based on wellbeing and promoting the common good; justice, fairness, and equity; legitimacy, trust, and sense of ownership in a pluralist society; combining and balancing ethical values and principles; adapting to changing conditions and evolving evidence; and linking ethical values and principles with policy goals and objectives.
Login to rate, favorite, and comments on the article
This roadmap provides guidance on COVID-19 vaccine prioritization decisions within countries based on various epidemiological setting and vaccine supply scenarios.
Login to rate, favorite, and comments on the article
This framework offers six core principles and twelve objectives to guide the prioritization of groups for COVID-19 vaccination when supply is limited.
Login to rate, favorite, and comments on the article
Vaccine Development and Approval
This page tracks the development status of the most promising COVID-19 vaccine candidates and global purchasing commitments for each.
Login to rate, favorite, and comments on the article
This frequently updated page provides a summary of vaccine candidates and trial timelines, key attributes of registered trials, a map of planning and ongoing efficacy trials, published safety, immunogenicity, and efficacy data, summary of vaccine distribution information, and frequently asked questions.
Login to rate, favorite, and comments on the article
This frequently updated page offers data visualizations tracking all COVID-19 vaccines currently in development by their platform and phase of clinical testing. Other visualizations show how vaccines work, describe the phases of development, and illustrate manufacturing scenarios.
Login to rate, favorite, and comments on the article
This memo summarizes U.S. government efforts to spur development of a vaccine to prevent COVID-19.
Login to rate, favorite, and comments on the article
This report documents the rationale supporting ACIP’s interim recommendation to use the Pfizer BioNTech vaccine in persons age 16 and older.
Login to rate, favorite, and comments on the article
This report documents the rationale supporting ACIP’s interim recommendation to use the Moderna vaccine in persons age 18 and older.
Login to rate, favorite, and comments on the article
This guidance document assists sponsors in the clinical development and licensure of vaccines to prevent COVID-19.
Login to rate, favorite, and comments on the article
This guidance document assists sponsors in understanding the data and information required to support the issuance of an emergency use authorization for a vaccine to prevent COVID-19.
Login to rate, favorite, and comments on the article
This graphic illustrates the key steps in the COVID-19 vaccine approval process.
Login to rate, favorite, and comments on the article
Vaccine Logistics - Distribution
This document provides an overview of the Pharmacy Partnership for Long-Term Care Program and answers frequently asked questions.
Login to rate, favorite, and comments on the article
This page provides answers to frequently asked questions about the Pharmacy Partnership for Long-Term Care Program.
Login to rate, favorite, and comments on the article
This page describes the Pharmacy Partnership for Long-Term Care Program that enables participating pharmacies to provide COVID-19 vaccination onsite at long-term care facilities.
Login to rate, favorite, and comments on the article
This document offers recommendations to owners and operators of cold storage facilities to prepare for cyber threats.
Login to rate, favorite, and comments on the article
This list of questions is intended to inform considerations of state, local, territorial, and tribal governments, private sector entities, and cold storage facility owners and operators related to physical security, cyber and infrastructure resiliency, personnel security, and incident response capabilities associated with COVID-19 vaccination logistics.
Login to rate, favorite, and comments on the article
This document outlines considerations for the security and integrity of facilities that receive, house, and distribute COVID-19 vaccine.
Login to rate, favorite, and comments on the article
This document provides handling information for owners and operators related to dry ice.
Login to rate, favorite, and comments on the article
This page describes McKesson’s role in the central distribution of COVID-19 vaccines and ancillary supplies.
Login to rate, favorite, and comments on the article
This paper discusses the processes and systems involved in the allocation, ordering, distribution, inventory management, tracking, administration, documentation, and reporting involved in the COVID-19 mass vaccination campaign.
Login to rate, favorite, and comments on the article
This memo offers actions to prepare for the mass distribution of COVID-19 vaccine.
Login to rate, favorite, and comments on the article
This page shares information on the role of CVS health in the national distribution of COVID-19 vaccine through the Vaccine Clinic Program.
Login to rate, favorite, and comments on the article
This page offers clickable maps to access each state’s COVID-19 vaccination plan and additional information from states conducting their own reviews of vaccines prior to distribution.
Login to rate, favorite, and comments on the article
This guidance allows state-licensed pharmacists to order and state-licensed pharmacists and registered pharmacy interns to administer COVID-19 vaccines under the Public Readiness and Emergency Preparedness Act when certain requirements are met.
Login to rate, favorite, and comments on the article
This press release announces a partnership with pharmacy chains representing 60 percent of the pharmacies in the U.S. to increase the number of COVID-19 vaccinators and vaccination sites available across the nation.
Login to rate, favorite, and comments on the article
This press release announces the Pharmacy Partnership for Long-Term Care Program through which CVS and Walgreens agreed to provide and administer COVID-19 vaccines on site to residents of skilled nursing facilities, nursing homes, assisted living facilities, residential care homes, and adult family homes as well as long-term care staff not already vaccinated via other efforts.
Login to rate, favorite, and comments on the article
This press release announces the ability of UPS to produce up to 1,200 pounds of dry ice per hour to support COVID-19 vaccine storage in U.S. and Canadian hospitals, clinics, and other points of care. It also announces a collaboration with Stirling Ultracold to distribute portable ultra-low temperature freezers to support ultra-cold chain requirements in smaller point of care facilities.
Login to rate, favorite, and comments on the article
This page offers information on the role of Walgreens in the national COVID-19 mass vaccination effort.
Login to rate, favorite, and comments on the article